Compare Definium Therapeutics Inc. Common Shares (DFTX) vs MaxLinear Inc. Common Stock (MXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs MaxLinear Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.8 (market cap $4.59B), while MaxLinear Inc. Common Stock trades at $96.37 (market cap $8.50B). The key difference: MaxLinear Inc. Common Stock is the larger of the two by market cap, and MaxLinear Inc. Common Stock is more actively traded (4,008,439 versus 2,103,937). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and MaxLinear Inc. Common Stock for 1 Days on average.
| DFTX | MXL | |
|---|---|---|
Market Cap | $4.59B | $8.50B |
Volume | 2,103,937 | 4,008,439 |
Sector | Health | Technology |
52-Week High | $48.45 | $128.03 |
52-Week Low | $10.68 | $13.05 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $3.55B | $8.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About MaxLinear Inc. Common Stock
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →
